United Services Automobile Association Novo Nordisk A S Transaction History

United Services Automobile Association

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $46.2 Million - $51.9 Million	-971,182 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$46.79 - $52.47 $743,025 - $833,223	-15,880 Reduced 1.61%	971,182 $49.6 Million
Q1 2019 May 13, 2019	SELL	$46.36 - $52.63 $1.08 Million - $1.23 Million	-23,349 Reduced 2.31%	987,062 $51.6 Million
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $1.04 Million - $1.18 Million	-24,924 Reduced 2.41%	1,010,411 $46.6 Million
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $6.27 Million - $6.87 Million	-134,082 Reduced 11.47%	1,035,335 $48.8 Million
Q2 2018 Sep 27, 2018	BUY	$44.29 - $50.42 $51.5 Million - $58.7 Million	1,163,385 Added 19286.89%	1,169,417 $53.9 Million
Q2 2018 Aug 10, 2018	SELL	$44.29 - $50.42 $52.2 Million - $59.5 Million	-1,179,413 Reduced 99.49%	6,032 $270,000
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $494,598 - $593,028	-10,200 Reduced 0.85%	1,185,445 $58.4 Million
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $421,258 - $476,208	-8,863 Reduced 0.74%	1,195,645 $64.2 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $49.6 Million - $59.3 Million	1,204,508	1,204,508 $58 Million

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.